• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Retrospective study shows toric IOL rotation rate to be low at 2.1%

Video

Edward Hu, MD, PhD, looked at 812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.

“In my experience and my opinion, it is possible that the extended haptic contact surface area with the capsular bag for the toric enVista platform may contribute to its superior rotation stability.”

Edward Hu, MD, PhD, gave a presentation during the 2022 ASCRS annual meeting on his four year retrospective analysis of comparative evaluation of clinically significant IOL rotations in his personal experience.

Looking at the use of over 812 Toric IOLs of various platforms, he concluded that the total Toric rotation rate in his experience was low at 2.1%

“In my experience and my opinion, it is possible that the extended haptic contact surface area with the capsular bag for the toric enVista platform may contribute to its superior rotation stability.”

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.